> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Panel to Meet on Barricaid Anular Closure Device
- URL: https://www.fdaweb.com/panel-to-meet-on-barricaid-anular-closure-device/
- Published: 2017-10-13T12:00:00.000Z
- Updated: 2026-09-14T22:55:57.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5139864

*Federal Register* notice: FDA has announced a 12/12 Orthopedic and Rehabilitation Devices Panel of the Medical Devices Advisory Committee meeting. Panel members will discuss, make recommendations, and vote on information regarding a Intrinsic Therapeutics PMA for the Barricaid Anular Closure Device, which is intended to be implanted following a limited discectomy to prevent reherniation and the recurrence of pain or dysfunction. It is indicated for patients with radiculopathy (with or without back pain), a posterior or posterolateral herniation, characterized by radiographic confirmation of neural compression using magnetic resonance imaging, and a large anular defect (e.g., between 4–6 mm tall and between 6–12 mm wide) post discectomy, at one level between L4 and S1\. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2017-10-13/pdf/2017-22174.pdf?ref=fdaweb.com).